Between Curing and Torturing: Burden of Adverse Reaction in Drug-Resistant Tuberculosis Therapy-Reference-Cited by-同舟云学术

Between Curing and Torturing: Burden of Adverse Reaction in Drug-Resistant Tuberculosis Therapy

Published:2021-11 Issue: Volume:Volume 15 Page:2597-2607
ISSN:1177-889X
Container-title:Patient Preference and Adherence
language:en
Short-container-title:PPA

Author:

Ausi Yudisia^ORCID,Santoso Prayudi^ORCID,Sunjaya Deni^ORCID,Barliana Melisa Intan^ORCID

Publisher

Informa UK Limited

Subject

Health Policy,Pharmacology, Toxicology and Pharmaceutics (miscellaneous),Social Sciences (miscellaneous),Medicine (miscellaneous)

Reference91 articles.

1. World Health Organization. WHO Consolidated Guidelines on Tuberculosis. Module 4: Treatment - Drug-Resistant Tuberculosis Treatment. Online Annexes. World Health Organization; 2020.

2. World Health Organization. Global Tuberculosis Report 2020. Geneva: World Health Organization; 2020.

3. World Health Organization. Safety of Medicines. Vol. 2. Geneva: World Health Organization; 2002.

4. Severe adverse events during second-line tuberculosis treatment in the context of high HIV Co-infection in South Africa: a retrospective cohort study

5. Adverse Events Associated With the Treatment of Multidrug-Resistant Tuberculosis

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Medication-related burden and its association with medication adherence among elderly tuberculosis patients in Guizhou, China: a cross-sectional study;Frontiers in Pharmacology;2024-08-29

2. Characteristics and contributing factors of adverse drug reactions: an analytical study of patients with tuberculosis receiving treatment under the National TB Program of India;F1000Research;2024-07-23

3. Assessing the quality of life in patients with drug-resistant tuberculosis: a cross-sectional study;BMC Pulmonary Medicine;2024-06-27

4. Effectiveness, cost, and safety of four regimens recommended by WHO for RR/MDR-TB treatment: a cohort study in Eastern China;Annals of Medicine;2024-05-02

5. Systematic review of efficacy and safety of shorter regimens for drug-resistant tuberculosis (DR-TB) in children;Clinical Epidemiology and Global Health;2024-05